Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
WuXi Biologics Receives AAA MSCI ESG Rating
2023-11-08 08:30
Rootique DUO launches on Indiegogo, revolutionizing hair loss treatment with a 15s mess-free process
2023-11-08 00:00
Nuevocor presents pre-clinical data at ESGCT and AHA meetings
2023-11-07 22:00
MAJOR FITNESS opens pre-orders on its less space, more exercises foldable power rack, the Lightning F35
2023-11-07 22:00
Recruitment target achieved for Phase II SAR-Bombesin prostate cancer trial
2023-11-07 21:58
Kexing Biopharm Attended CPHI Worldwide 2023
2023-11-07 20:09
Akeso's Cadonilimab (PD-1/CTLA-4) Phase III Trial Meets Primary Endpoint at Interim Analysis Demonstrating Strong Overall Survival Benefit as First-line Treatment in All-comer Patients with Gastric Cancer or Gastroesophageal Junction Adenocarcinoma (GC/GEJC)
2023-11-07 20:00
First Mover of Global Trade Index Based On Biome Molecule, Kwanyoung Park of AndKwan Natural Science
2023-11-07 15:47
BioRay Announces First-Patient-In for Phase I Clinical Study of BRY812, a Novel LIV-1 Targeting Antibody Drug Conjugate
2023-11-07 14:14
87.5% ORR | Abbisko presented two clinical updates of Pimicotinib at the 2023 CTOS Annual Meeting
2023-11-07 12:31
AIRS Medical inks partnership agreement with FONAR Corporation, leveraging the experience of the pioneering company in MRI... Success cases to be presented at RSNA 2023
2023-11-07 00:00
Lerna Bio unveils its first-in-class solution to combat liver failure
2023-11-06 22:00
First in the U.S! Palliative Care VR Educational Material by Jolly Good and Emergency Medicine Specialists
2023-11-06 21:00
Lunit to Present Seven AI-Powered Radiology Studies at RSNA 2023
2023-11-06 21:00
I-Mab Announces Participation at Jefferies and Piper Conferences in November
2023-11-06 21:00
Biotheus Enters Into Strategic Partnership with BioNTech to Develop and Commercialize Bispecific Antibody Candidate Targeting PD-L1 and VEGF in Multiple Solid Tumor Indications
2023-11-06 20:00
Dr.FORHAIR Announces U.S. In-Store Launch of Best Selling Hair Loss Shampoo
2023-11-06 16:48
David Beckham Signs Deal with TEMPUR to Promote The Benefits Of Sleep
2023-11-06 11:00
The World's First "Recombinant Anthrax Vaccine": GC Biopharma applies for MFDS Approval
2023-11-06 09:11
PillWork's Upcoming Launch and its Landmark Partnership with Precision Nutrition Association
2023-11-06 09:00
1
65
66
67
68
69
800